维普中文期刊产品整合服务
116篇 您的检索式:作者名="DOGGRELL SA"
    题名 作者 年代 出处 被引量
1Recent important clinical trials of drugs inosteoporosis显示文摘Doggrell SA 2004Expert Opin Pharmacother2004,5,7:1
2Tolvaptan (Otsuka)显示文摘Doggrell SA 2004Curr Opin Investig Drugs2004,5,9:1
3Telmisartan-killing two birds with one stone显示文摘Doggrell SA 2004Expert Opin Pharmacother2004,5,11:1
4Recent important clinical trials of drugs in osteoporosis显示文摘Doggrell SA 2004Expert Opin Pharmacother2004,5,7:1
5Sirolimus-or paclitaxel-eluting stents for coronary artery revascularisation显示文摘Doggrell SA 2006Expert Opin Pharmacother2006,7,2:1
6The Spironolactone renaissance显示文摘Doggrell SA Brown L 2001Expert Opin Investing Drugs2001,10,5:1
7Carvedilol versus other beta-blockers in heart failur e 显示文摘Doggrell SA 2001Expert Opin Investig Drugs2001,10,5:1
8Present and future pharmacotherapy for osteoporosis显示文摘Doggrell SA 2003Drugs Today (Barc)2003,39,8:1
9Inhibitors of cholesteryl ester transfer protein a new approach to coronary artery disease 显示文摘Doggrell SA 2006Expert Opin Invest Drags2006,15,2:1
10Candesartan for the prevention and treatment of stroke - results of the SCOPE and ACCESS trials显示文摘Doggrell SA 2004Expert Opin Pharmacother2004,50,3:1
11The role of 5-HT on the cardiovascular and renal systems and the clinical potential of 5-HT modulation显示文摘Doggrell SA 2003Expert Opin Invest Drugs2003,12,5:1
12Present and future pharmacotherapy for osteoporosis显示文摘Doggrell SA 2003Drugs Today(Barc)2003,39,8:1
13Telmisartan-killing two birds with one stone显示文摘Doggrell SA 2004Expert Opin Pharmacother2004,5,11:1
14The role of 5-HT on the cardiovascular and renal systens and the clonical potention of 5-HT modulation显示文摘Doggrell SA 2003Expert Opin Investing Drugs2003,12,5:1
15Does the p38 MAP kinase inhibitor pamapimod have potential for the treatment of rheumatoid arthritis显示文摘Doggrell SA ChristensenAM 2010Expert Opin Pharmaeother2010,11,14:1
16The spironolactone renaissance显示文摘Doggrell SA Brown L 2001Exp Opin Invest Drugs2001,10,5:1
17A neuroprotective derivative of erythropoietin that is not erythropoietie 显示文摘Doggrell SA 2004Expert Opin Investig Drugs2004,13,11:1
18The spironolactone renaissance 显示文摘Doggrell SA Brown L 2001Expert Opin Invest Drugs2001,10,5:1
19Recent important clinical trials of drugs in osteoporosis显示文摘Doggrell SA 2004Expert Opin Pharmacyother2004,5,7:1
20Present and future pharmacotherapy for osteoporosis 显示文摘Doggrell SA 2003Drugs Today ( Barc)2003,39,8:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费